Biopharma, the Kyiv-based producer of blood-derived products, is to boost exports by 40% this month, to $4.6 million.

Biopharma, the Kyiv-based producer of blood-derived products, is to boost exports by 40% this month, to $4.6 million. Already selling to eight countries, Biopharma adds Bangladesh and Colombia this month. Boosted by investment from Horizon Capital and FMO, the Dutch development bank, Biopharma has become Ukraine’s leader in producing blood plasma protein products.